Bio

• Foundation Chairman & Scientific Director of the not-for-profit Institute for Innovation & Valuation in Health Care (InnoVal^HC, since June 2005)
• Univ-Prof. em. of Health Economics at the University of Heidelberg and Head of the former Division of Health Economics at the German Cancer Research Center (DKFZ), Heidelberg / Germany (2017-2025)
• Founder & Head of the Task Force on “Socioeconomic Impact Research” of the Organisation of European Cancer Institutes (OECI, since March 2021)

Michael Schlander has taught health economics and [health care & innovation] management at the University of Heidelberg (since 2007; previously at the University of Duisburg-Essen, Faculty of Medicine, 2005-2008, at the University of Witten/Herdecke, Faculty of Medicine, 1996-2005) and at the University of Applied [Economic] Sciences Ludwigshafen (2002-2016).

Prior to his permanent university appointment in 2002, he spent fifteen years in executive positions with international research-based biopharmaceutical companies in Germany, Belgium, Switzerland, and the United States of America.

Before joining industry, he had spent six years in experimental brain research and clinical neurology at two German universities.